FCN-589

N/A

Report date: 2023/05/22 10:17:11

Base Information

Drug NameFCN-589
Drug Alias NameFCN-589
ClassificationSmall molecules
Mechanisms of ActionBTK C481S inhibitors
TargetsBTK C481S
Therapy Area/IndicationsLeukemia, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesFochon Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsLeukemia, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A